Skip to main content
Caplight Logo









Surginex

Surginex

Private
SeoulHealthcare & Life Scienceshttps://www.surginex.com/

Last Round

Series B

Mar 28, 2024

Total Funding Raised

$9.69M

Company Overview

Surginex is a biotechnology company that develops AI-based drug discovery platforms and next-generation lipid nanoparticle (LNP) technology for targeted drug delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

LNPlipid nanoparticledrug deliveryRNA deliverydrug delivery platformnucleic acid therapeuticsionizable lipidsgene therapydelivery techin-silico drug discoverymRNA deliverybiotech R&DCAR-T therapyCRISPR-Cas9AI drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Surginex Comparables

Compare Surginex with similar companies based on industry and business-model similarity.

Surginex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genevant Sciences
84%
Hopewell Therapeutics
82%
Acuitas Therapeutics
79%

Surginex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 28, 2024
Series AOct 18, 2021

Surginex Investors

Notable investors and investment history

Surginex investors
InvestorRounds
Hana VenturesSeries B
POSCO CapitalSeries B
K-Net Investment PartnersSeries A
Kiwoom InvestmentSeries B
LSK InvestmentSeries B
Kiwoom InvestmentSeries B
Partners InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 28, 2024

    $6.3M round with participation from Kiwoom Investment and POSCO Technology Investment.

Surginex Filings

Explore SEC and related filing metadata, where available.

Surginex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Surginex's valuation, stock price, and market status.

Is Surginex a public or private company?

Surginex is a private company.

What is the current stock price of Surginex?

Surginex is a private company with no public stock price. No recent secondary market data is available.

How much is Surginex worth (valuation)?

Valuation information for Surginex is not publicly available.

Can I buy Surginex stock?

Surginex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Surginex's last funding round?

Surginex's most recent funding round was Series B on March 28, 2024.

Who are the main investors in Surginex?

Key investors in Surginex include Hana Ventures, POSCO Capital, K-Net Investment Partners, Kiwoom Investment, LSK Investment.

Will Surginex IPO soon?

No public IPO plans have been announced for Surginex.

How can I track Surginex secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Surginex's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Year Founded2020
Last FundingMar 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?